Immune checkpoint inhibitor-associated diabetes mellitus: the case series report
This report aims to better define the rare adverse event of immune checkpoint inhibitor-associated diabetes mellitus(ICI-DM). We present 10 cases of patients including six of the patients had no prior history of diabetes, while four had varying degrees of pre-existing diabetes. Eight who received an...
Saved in:
Main Authors: | Yuhong Ma, Jing Xue, Qianwen Cheng, Hesheng Qian, Yingying Du |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1589630/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endocrine adverse events of immune checkpoint inhibitors: results of a single-center study
by: E. V. Poddubskaya, et al.
Published: (2019-12-01) -
Adverse reactions of immune checkpoint inhibitors
by: E. R. Zagidullina, et al.
Published: (2025-06-01) -
Neurotoxicity in the Era of Immune Checkpoint Inhibitors: A Case-Based Approach
by: Özkan ALAN, et al.
Published: (2025-04-01) -
Case Report: Tislelizumab-induced insulin-dependent diabetes mellitus: a case report and literature review
by: Panpan Ji, et al.
Published: (2025-07-01) -
Arthropathy associated with antitumor checkpoint inhibitors therapy: current understanding of the problem
by: A. D. Koltakova, et al.
Published: (2023-10-01)